 Alexander Kaizer
Concepts (412)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Research Design | 9 | 2022 | 931 | 1.520 |
Why?
| | Atrioventricular Block | 4 | 2022 | 37 | 1.260 |
Why?
| | Bayes Theorem | 10 | 2022 | 331 | 1.120 |
Why?
| | Heart Rate, Fetal | 2 | 2023 | 20 | 1.050 |
Why?
| | Long QT Syndrome | 2 | 2023 | 59 | 0.990 |
Why?
| | Models, Statistical | 3 | 2018 | 604 | 0.950 |
Why?
| | Gastroesophageal Reflux | 6 | 2023 | 234 | 0.940 |
Why?
| | Bariatric Surgery | 6 | 2020 | 161 | 0.840 |
Why?
| | Medical Futility | 1 | 2022 | 19 | 0.820 |
Why?
| | Weight Loss | 8 | 2023 | 642 | 0.820 |
Why?
| | Obesity, Morbid | 6 | 2020 | 197 | 0.810 |
Why?
| | Ritonavir | 1 | 2022 | 71 | 0.810 |
Why?
| | Neoplasms | 4 | 2023 | 2105 | 0.790 |
Why?
| | Tobacco Products | 2 | 2020 | 98 | 0.780 |
Why?
| | Lupus Erythematosus, Systemic | 2 | 2022 | 221 | 0.710 |
Why?
| | Neostigmine | 1 | 2020 | 4 | 0.700 |
Why?
| | Pediatric Obesity | 8 | 2020 | 489 | 0.690 |
Why?
| | Humans | 97 | 2024 | 114756 | 0.670 |
Why?
| | Esophageal Achalasia | 3 | 2023 | 25 | 0.640 |
Why?
| | Data Collection | 1 | 2021 | 622 | 0.630 |
Why?
| | Spinal Cord Stimulation | 3 | 2024 | 7 | 0.630 |
Why?
| | Biostatistics | 1 | 2018 | 16 | 0.610 |
Why?
| | Laryngopharyngeal Reflux | 3 | 2023 | 13 | 0.600 |
Why?
| | Therapeutics | 1 | 2018 | 12 | 0.600 |
Why?
| | Anaphylaxis | 1 | 2020 | 148 | 0.580 |
Why?
| | Esophageal Motility Disorders | 3 | 2023 | 23 | 0.570 |
Why?
| | Clinical Protocols | 1 | 2018 | 232 | 0.540 |
Why?
| | Fetal Diseases | 4 | 2023 | 147 | 0.540 |
Why?
| | Data Interpretation, Statistical | 1 | 2018 | 322 | 0.530 |
Why?
| | Antibodies, Antinuclear | 3 | 2022 | 60 | 0.530 |
Why?
| | Retrospective Studies | 28 | 2024 | 12515 | 0.510 |
Why?
| | Tobacco Use Disorder | 1 | 2018 | 234 | 0.510 |
Why?
| | Ixodidae | 1 | 2015 | 5 | 0.500 |
Why?
| | Mucopolysaccharidosis I | 3 | 2019 | 9 | 0.480 |
Why?
| | Manometry | 7 | 2023 | 89 | 0.470 |
Why?
| | Larva | 1 | 2015 | 194 | 0.470 |
Why?
| | Prospective Studies | 19 | 2023 | 6217 | 0.460 |
Why?
| | Pepsin A | 3 | 2023 | 18 | 0.450 |
Why?
| | Anti-Obesity Agents | 3 | 2019 | 45 | 0.420 |
Why?
| | Esophagitis, Peptic | 2 | 2023 | 16 | 0.410 |
Why?
| | Analgesics, Opioid | 6 | 2022 | 773 | 0.410 |
Why?
| | Brachial Plexus Block | 2 | 2022 | 3 | 0.410 |
Why?
| | Esophageal pH Monitoring | 5 | 2023 | 23 | 0.400 |
Why?
| | Obesity | 5 | 2023 | 2513 | 0.400 |
Why?
| | Proton Pump Inhibitors | 6 | 2023 | 96 | 0.390 |
Why?
| | Treatment Outcome | 15 | 2023 | 9089 | 0.370 |
Why?
| | Anesthetics | 2 | 2022 | 54 | 0.370 |
Why?
| | Randomized Controlled Trials as Topic | 3 | 2022 | 1214 | 0.360 |
Why?
| | Nerve Block | 3 | 2021 | 62 | 0.360 |
Why?
| | Female | 42 | 2023 | 59507 | 0.350 |
Why?
| | Analgesia, Epidural | 2 | 2021 | 20 | 0.340 |
Why?
| | Body Contouring | 2 | 2020 | 8 | 0.340 |
Why?
| | Enzyme Replacement Therapy | 2 | 2019 | 10 | 0.340 |
Why?
| | Injections, Spinal | 2 | 2019 | 101 | 0.330 |
Why?
| | Pregnancy | 8 | 2023 | 5525 | 0.310 |
Why?
| | Adult | 25 | 2024 | 30548 | 0.310 |
Why?
| | Esophagus | 2 | 2020 | 226 | 0.300 |
Why?
| | Pain, Postoperative | 5 | 2022 | 191 | 0.300 |
Why?
| | Surgeons | 2 | 2021 | 238 | 0.290 |
Why?
| | Probability | 3 | 2022 | 291 | 0.290 |
Why?
| | Anesthetics, Local | 3 | 2022 | 83 | 0.270 |
Why?
| | Nicotine | 2 | 2020 | 265 | 0.270 |
Why?
| | Child | 17 | 2023 | 18352 | 0.250 |
Why?
| | Pregnancy Outcome | 3 | 2023 | 337 | 0.250 |
Why?
| | Male | 34 | 2023 | 55579 | 0.250 |
Why?
| | Bupivacaine | 2 | 2022 | 31 | 0.250 |
Why?
| | Incidence | 6 | 2023 | 2312 | 0.240 |
Why?
| | Hearing Aids | 2 | 2023 | 70 | 0.240 |
Why?
| | Laparoscopy | 2 | 2020 | 388 | 0.240 |
Why?
| | Body Weight | 2 | 2019 | 869 | 0.230 |
Why?
| | Adrenergic beta-Antagonists | 2 | 2023 | 287 | 0.230 |
Why?
| | Intraoperative Neurophysiological Monitoring | 1 | 2024 | 15 | 0.230 |
Why?
| | Hearing Loss, Sudden | 1 | 2023 | 8 | 0.220 |
Why?
| | Myotomy | 1 | 2023 | 8 | 0.220 |
Why?
| | Atrial Flutter | 1 | 2023 | 25 | 0.220 |
Why?
| | Sample Size | 2 | 2021 | 114 | 0.220 |
Why?
| | Tachycardia, Supraventricular | 1 | 2023 | 42 | 0.210 |
Why?
| | Intrauterine Devices, Medicated | 1 | 2023 | 23 | 0.210 |
Why?
| | Intestinal Atresia | 1 | 2023 | 16 | 0.210 |
Why?
| | Hearing Loss, Sensorineural | 1 | 2023 | 60 | 0.210 |
Why?
| | Lopinavir | 1 | 2022 | 29 | 0.210 |
Why?
| | Postoperative Complications | 4 | 2021 | 2127 | 0.210 |
Why?
| | Lidocaine | 1 | 2023 | 41 | 0.210 |
Why?
| | Fetal Heart | 2 | 2019 | 37 | 0.210 |
Why?
| | Immunosorbents | 1 | 2022 | 1 | 0.210 |
Why?
| | Neutropenia | 1 | 2023 | 125 | 0.210 |
Why?
| | Telemedicine | 2 | 2021 | 663 | 0.200 |
Why?
| | Hepatectomy | 1 | 2023 | 119 | 0.200 |
Why?
| | Current Procedural Terminology | 1 | 2022 | 11 | 0.200 |
Why?
| | Tremor | 1 | 2022 | 45 | 0.200 |
Why?
| | Adolescent | 17 | 2023 | 17808 | 0.200 |
Why?
| | Diaphragm | 2 | 2022 | 31 | 0.200 |
Why?
| | Tympanoplasty | 1 | 2022 | 7 | 0.200 |
Why?
| | Tympanic Membrane Perforation | 1 | 2022 | 12 | 0.200 |
Why?
| | Hydroxychloroquine | 1 | 2022 | 55 | 0.200 |
Why?
| | Deafness | 1 | 2023 | 79 | 0.200 |
Why?
| | Enterocolitis, Neutropenic | 1 | 2021 | 5 | 0.190 |
Why?
| | Funnel Chest | 1 | 2021 | 20 | 0.190 |
Why?
| | Multiple Pulmonary Nodules | 1 | 2021 | 22 | 0.190 |
Why?
| | Epidermolysis Bullosa | 1 | 2022 | 41 | 0.190 |
Why?
| | Infant, Newborn | 5 | 2023 | 5035 | 0.190 |
Why?
| | Fetus | 2 | 2023 | 699 | 0.190 |
Why?
| | Carcinoma, Transitional Cell | 1 | 2022 | 53 | 0.190 |
Why?
| | Psychological Trauma | 1 | 2022 | 54 | 0.190 |
Why?
| | Paranasal Sinus Neoplasms | 1 | 2021 | 17 | 0.190 |
Why?
| | Nose Neoplasms | 1 | 2021 | 15 | 0.190 |
Why?
| | Patient Handoff | 1 | 2021 | 26 | 0.190 |
Why?
| | Disabled Persons | 1 | 2023 | 132 | 0.190 |
Why?
| | Tumor Burden | 1 | 2022 | 261 | 0.190 |
Why?
| | Prostate | 1 | 2022 | 156 | 0.190 |
Why?
| | Eructation | 1 | 2021 | 2 | 0.190 |
Why?
| | Hernia, Hiatal | 1 | 2021 | 32 | 0.190 |
Why?
| | Prenatal Diagnosis | 2 | 2019 | 167 | 0.190 |
Why?
| | Congenital Microtia | 1 | 2020 | 4 | 0.190 |
Why?
| | Cardiopulmonary Resuscitation | 1 | 2023 | 220 | 0.190 |
Why?
| | Computer Simulation | 3 | 2022 | 878 | 0.190 |
Why?
| | Cardiovascular Diseases | 3 | 2023 | 1727 | 0.190 |
Why?
| | Prevalence | 3 | 2023 | 2249 | 0.190 |
Why?
| | Medicare Part D | 1 | 2021 | 26 | 0.190 |
Why?
| | Spinal Cord Injuries | 1 | 2024 | 172 | 0.180 |
Why?
| | Pregnant Women | 1 | 2022 | 131 | 0.180 |
Why?
| | Specialties, Surgical | 1 | 2022 | 70 | 0.180 |
Why?
| | Cystectomy | 1 | 2021 | 32 | 0.180 |
Why?
| | Exercise | 3 | 2020 | 1644 | 0.180 |
Why?
| | Ear | 1 | 2020 | 32 | 0.180 |
Why?
| | Bias | 1 | 2021 | 180 | 0.180 |
Why?
| | Electrocardiography | 1 | 2023 | 562 | 0.180 |
Why?
| | Shock | 1 | 2021 | 75 | 0.180 |
Why?
| | Drug Costs | 1 | 2021 | 91 | 0.180 |
Why?
| | Predictive Value of Tests | 2 | 2022 | 1796 | 0.180 |
Why?
| | Ocular Hypertension | 1 | 2021 | 61 | 0.180 |
Why?
| | Substance Abuse Detection | 1 | 2021 | 62 | 0.180 |
Why?
| | Information Dissemination | 1 | 2022 | 187 | 0.180 |
Why?
| | Anesthesia | 1 | 2022 | 117 | 0.180 |
Why?
| | Congenital Abnormalities | 1 | 2020 | 73 | 0.170 |
Why?
| | Carcinoma | 1 | 2021 | 198 | 0.170 |
Why?
| | Heart Arrest | 1 | 2023 | 289 | 0.170 |
Why?
| | Parenteral Nutrition | 1 | 2021 | 96 | 0.170 |
Why?
| | Magnetocardiography | 1 | 2019 | 2 | 0.170 |
Why?
| | Hearing Loss | 1 | 2023 | 184 | 0.170 |
Why?
| | Tracheostomy | 1 | 2021 | 100 | 0.170 |
Why?
| | Glaucoma, Open-Angle | 1 | 2021 | 95 | 0.170 |
Why?
| | Speech Perception | 1 | 2021 | 79 | 0.170 |
Why?
| | Enteral Nutrition | 1 | 2021 | 157 | 0.170 |
Why?
| | Hyperplasia | 1 | 2020 | 163 | 0.170 |
Why?
| | Spine | 1 | 2021 | 135 | 0.170 |
Why?
| | Infant | 5 | 2023 | 7935 | 0.160 |
Why?
| | Urinary Bladder Neoplasms | 1 | 2022 | 196 | 0.160 |
Why?
| | Cochlear Implantation | 1 | 2021 | 80 | 0.160 |
Why?
| | Perioperative Care | 1 | 2020 | 126 | 0.160 |
Why?
| | Stillbirth | 1 | 2019 | 57 | 0.160 |
Why?
| | Cochlear Implants | 1 | 2021 | 94 | 0.160 |
Why?
| | Drug Prescriptions | 1 | 2021 | 239 | 0.160 |
Why?
| | Intra-Abdominal Fat | 1 | 2019 | 77 | 0.160 |
Why?
| | Medically Underserved Area | 1 | 2019 | 81 | 0.160 |
Why?
| | Depressive Disorder, Major | 1 | 2022 | 299 | 0.160 |
Why?
| | Electrocardiography, Ambulatory | 1 | 2019 | 54 | 0.160 |
Why?
| | Pregnancy Complications, Infectious | 1 | 2023 | 288 | 0.160 |
Why?
| | Body Weight Maintenance | 1 | 2019 | 15 | 0.160 |
Why?
| | Aged | 12 | 2024 | 19094 | 0.160 |
Why?
| | Outpatients | 1 | 2022 | 327 | 0.160 |
Why?
| | Cardiotocography | 1 | 2018 | 3 | 0.160 |
Why?
| | Cell-Derived Microparticles | 1 | 2019 | 57 | 0.160 |
Why?
| | Abortion, Spontaneous | 1 | 2019 | 90 | 0.160 |
Why?
| | Home Care Services, Hospital-Based | 1 | 2018 | 10 | 0.160 |
Why?
| | Cannabinoids | 1 | 2020 | 115 | 0.160 |
Why?
| | Nutritional Status | 1 | 2021 | 286 | 0.160 |
Why?
| | Body Mass Index | 4 | 2023 | 1958 | 0.160 |
Why?
| | Genotype | 1 | 2023 | 1774 | 0.160 |
Why?
| | Phenotype | 2 | 2023 | 2812 | 0.160 |
Why?
| | Soaps | 1 | 2018 | 10 | 0.160 |
Why?
| | Baths | 1 | 2018 | 17 | 0.160 |
Why?
| | Postoperative Nausea and Vomiting | 1 | 2018 | 10 | 0.150 |
Why?
| | Pain Management | 1 | 2021 | 289 | 0.150 |
Why?
| | Gastroenterology | 1 | 2020 | 159 | 0.150 |
Why?
| | Glaucoma | 1 | 2021 | 202 | 0.150 |
Why?
| | Adaptive Clinical Trials as Topic | 1 | 2018 | 19 | 0.150 |
Why?
| | Anti-Infective Agents, Local | 1 | 2018 | 40 | 0.150 |
Why?
| | Africa, Western | 1 | 2018 | 16 | 0.150 |
Why?
| | Ultrasonography, Prenatal | 1 | 2019 | 236 | 0.150 |
Why?
| | Parkinson Disease | 1 | 2022 | 345 | 0.150 |
Why?
| | Risk Factors | 9 | 2023 | 8627 | 0.150 |
Why?
| | Middle Aged | 13 | 2023 | 26757 | 0.150 |
Why?
| | Ovarian Neoplasms | 1 | 2022 | 388 | 0.150 |
Why?
| | Hemorrhagic Fever, Ebola | 1 | 2018 | 33 | 0.150 |
Why?
| | Barrett Esophagus | 1 | 2020 | 147 | 0.150 |
Why?
| | Burns | 1 | 2021 | 237 | 0.150 |
Why?
| | Thoracic Surgery, Video-Assisted | 1 | 2017 | 40 | 0.140 |
Why?
| | Dyslipidemias | 1 | 2019 | 154 | 0.140 |
Why?
| | Respiration, Artificial | 1 | 2021 | 526 | 0.140 |
Why?
| | Penicillin Resistance | 1 | 2017 | 8 | 0.140 |
Why?
| | Serogroup | 1 | 2017 | 26 | 0.140 |
Why?
| | Disinfection | 1 | 2018 | 106 | 0.140 |
Why?
| | Child Behavior | 1 | 2019 | 220 | 0.140 |
Why?
| | Pancreaticoduodenectomy | 1 | 2018 | 133 | 0.140 |
Why?
| | Phentermine | 1 | 2016 | 8 | 0.140 |
Why?
| | United States | 9 | 2024 | 12176 | 0.140 |
Why?
| | Echocardiography | 1 | 2019 | 554 | 0.140 |
Why?
| | Transcatheter Aortic Valve Replacement | 1 | 2019 | 152 | 0.140 |
Why?
| | Cigarette Smoking | 1 | 2018 | 72 | 0.140 |
Why?
| | Blood Platelets | 1 | 2019 | 351 | 0.140 |
Why?
| | Antiviral Agents | 1 | 2022 | 646 | 0.140 |
Why?
| | Gestational Age | 4 | 2019 | 759 | 0.140 |
Why?
| | Mentoring | 1 | 2018 | 101 | 0.130 |
Why?
| | Pneumonectomy | 1 | 2017 | 125 | 0.130 |
Why?
| | Disease Models, Animal | 2 | 2023 | 3542 | 0.130 |
Why?
| | Suicide | 1 | 2022 | 502 | 0.130 |
Why?
| | Fructose | 1 | 2016 | 100 | 0.130 |
Why?
| | Internal Medicine | 1 | 2018 | 211 | 0.130 |
Why?
| | Heart-Assist Devices | 1 | 2022 | 485 | 0.130 |
Why?
| | Spinal Cord | 3 | 2024 | 347 | 0.130 |
Why?
| | Pneumococcal Infections | 1 | 2017 | 91 | 0.130 |
Why?
| | Anti-Bacterial Agents | 2 | 2023 | 1477 | 0.130 |
Why?
| | Reproducibility of Results | 5 | 2021 | 2763 | 0.130 |
Why?
| | Heart Transplantation | 1 | 2022 | 667 | 0.130 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 1 | 2018 | 191 | 0.130 |
Why?
| | Body Composition | 1 | 2019 | 592 | 0.130 |
Why?
| | Length of Stay | 4 | 2021 | 949 | 0.130 |
Why?
| | Cross-Sectional Studies | 6 | 2023 | 4409 | 0.130 |
Why?
| | Critical Illness | 1 | 2021 | 643 | 0.130 |
Why?
| | Faculty, Medical | 1 | 2018 | 228 | 0.130 |
Why?
| | Streptococcus pneumoniae | 1 | 2017 | 134 | 0.130 |
Why?
| | Adiposity | 2 | 2019 | 457 | 0.130 |
Why?
| | Surgical Wound Infection | 1 | 2018 | 248 | 0.130 |
Why?
| | Surveys and Questionnaires | 3 | 2022 | 4625 | 0.130 |
Why?
| | Aortic Valve Stenosis | 1 | 2019 | 272 | 0.130 |
Why?
| | Cognitive Dysfunction | 1 | 2019 | 284 | 0.120 |
Why?
| | Precision Medicine | 1 | 2019 | 338 | 0.120 |
Why?
| | Lung Diseases | 1 | 2022 | 696 | 0.120 |
Why?
| | Missouri | 1 | 2015 | 61 | 0.120 |
Why?
| | Meals | 1 | 2016 | 103 | 0.120 |
Why?
| | Hematopoietic Stem Cell Transplantation | 2 | 2019 | 524 | 0.120 |
Why?
| | Disease Outbreaks | 1 | 2018 | 309 | 0.120 |
Why?
| | Pilot Projects | 4 | 2021 | 1370 | 0.120 |
Why?
| | Forests | 1 | 2015 | 48 | 0.120 |
Why?
| | Veterans | 2 | 2022 | 1240 | 0.120 |
Why?
| | Wounds and Injuries | 1 | 2022 | 723 | 0.120 |
Why?
| | Stress Disorders, Post-Traumatic | 1 | 2022 | 755 | 0.120 |
Why?
| | Hypertension | 1 | 2022 | 1059 | 0.120 |
Why?
| | Hypoxia | 1 | 2020 | 957 | 0.110 |
Why?
| | Pregnancy Complications | 1 | 2018 | 429 | 0.110 |
Why?
| | Opioid-Related Disorders | 1 | 2021 | 413 | 0.110 |
Why?
| | Cannabis | 1 | 2020 | 384 | 0.110 |
Why?
| | Clinical Competence | 1 | 2020 | 896 | 0.110 |
Why?
| | Mothers | 1 | 2019 | 651 | 0.110 |
Why?
| | Feeding Behavior | 1 | 2019 | 574 | 0.110 |
Why?
| | Medicare | 3 | 2024 | 665 | 0.110 |
Why?
| | Endothelium, Vascular | 1 | 2019 | 843 | 0.110 |
Why?
| | Hospitalization | 1 | 2022 | 1752 | 0.110 |
Why?
| | Heart Defects, Congenital | 1 | 2019 | 665 | 0.110 |
Why?
| | Physicians | 1 | 2021 | 772 | 0.110 |
Why?
| | Esophagogastric Junction | 2 | 2023 | 42 | 0.110 |
Why?
| | Muscle Spasticity | 2 | 2023 | 53 | 0.110 |
Why?
| | Seasons | 1 | 2015 | 450 | 0.110 |
Why?
| | Minnesota | 3 | 2018 | 134 | 0.100 |
Why?
| | Intensive Care Units | 3 | 2021 | 618 | 0.100 |
Why?
| | Lung | 2 | 2022 | 3546 | 0.100 |
Why?
| | Mental Health | 1 | 2018 | 560 | 0.100 |
Why?
| | Internship and Residency | 1 | 2022 | 932 | 0.100 |
Why?
| | Insulin Resistance | 1 | 2020 | 1072 | 0.100 |
Why?
| | Cognition | 1 | 2019 | 989 | 0.100 |
Why?
| | Electric Impedance | 2 | 2023 | 100 | 0.100 |
Why?
| | Animals | 4 | 2023 | 31761 | 0.100 |
Why?
| | Anxiety | 1 | 2018 | 842 | 0.100 |
Why?
| | Heartburn | 2 | 2021 | 11 | 0.100 |
Why?
| | Monitoring, Ambulatory | 2 | 2023 | 81 | 0.090 |
Why?
| | Antineoplastic Agents | 1 | 2022 | 1895 | 0.090 |
Why?
| | Cohort Studies | 4 | 2021 | 4901 | 0.090 |
Why?
| | Hydrogen-Ion Concentration | 2 | 2023 | 511 | 0.090 |
Why?
| | Operating Rooms | 2 | 2022 | 87 | 0.090 |
Why?
| | Saliva | 2 | 2023 | 189 | 0.090 |
Why?
| | Ecosystem | 1 | 2015 | 515 | 0.090 |
Why?
| | Swine | 2 | 2023 | 700 | 0.090 |
Why?
| | Medical Oncology | 2 | 2022 | 229 | 0.090 |
Why?
| | Cesarean Section | 2 | 2023 | 169 | 0.090 |
Why?
| | Depression | 1 | 2018 | 1133 | 0.090 |
Why?
| | Operative Time | 2 | 2022 | 106 | 0.080 |
Why?
| | Time Factors | 4 | 2022 | 6124 | 0.080 |
Why?
| | Prognosis | 3 | 2023 | 3334 | 0.080 |
Why?
| | Tertiary Care Centers | 2 | 2022 | 126 | 0.080 |
Why?
| | Lung Neoplasms | 1 | 2021 | 2199 | 0.080 |
Why?
| | Ultrasonography, Interventional | 2 | 2021 | 123 | 0.080 |
Why?
| | Child, Preschool | 5 | 2021 | 9079 | 0.080 |
Why?
| | Sensitivity and Specificity | 2 | 2023 | 1691 | 0.080 |
Why?
| | Pain Measurement | 2 | 2022 | 445 | 0.070 |
Why?
| | Feasibility Studies | 2 | 2022 | 737 | 0.070 |
Why?
| | Follow-Up Studies | 3 | 2021 | 4420 | 0.070 |
Why?
| | Mice | 1 | 2022 | 14916 | 0.070 |
Why?
| | Caregivers | 2 | 2023 | 717 | 0.060 |
Why?
| | Anesthesia, General | 1 | 2024 | 45 | 0.060 |
Why?
| | Hydrops Fetalis | 1 | 2023 | 13 | 0.060 |
Why?
| | Digoxin | 1 | 2023 | 26 | 0.060 |
Why?
| | Case-Control Studies | 2 | 2021 | 3005 | 0.060 |
Why?
| | Esophageal Sphincter, Lower | 1 | 2023 | 10 | 0.050 |
Why?
| | Pandemics | 2 | 2022 | 1319 | 0.050 |
Why?
| | Tachycardia | 1 | 2023 | 50 | 0.050 |
Why?
| | Longitudinal Studies | 2 | 2020 | 2386 | 0.050 |
Why?
| | Anti-Arrhythmia Agents | 1 | 2023 | 106 | 0.050 |
Why?
| | Edema | 1 | 2023 | 118 | 0.050 |
Why?
| | Epinephrine | 1 | 2023 | 164 | 0.050 |
Why?
| | Tomography, X-Ray Computed | 2 | 2022 | 2269 | 0.050 |
Why?
| | Fingers | 1 | 2022 | 83 | 0.050 |
Why?
| | Goals | 1 | 2023 | 149 | 0.050 |
Why?
| | Motor Skills | 1 | 2022 | 81 | 0.050 |
Why?
| | Rotator Cuff | 1 | 2022 | 43 | 0.050 |
Why?
| | False Positive Reactions | 1 | 2022 | 108 | 0.050 |
Why?
| | Esophageal Sphincter, Upper | 1 | 2021 | 5 | 0.050 |
Why?
| | Patients | 1 | 2023 | 162 | 0.050 |
Why?
| | Proton Pumps | 1 | 2021 | 8 | 0.050 |
Why?
| | Meta-Analysis as Topic | 1 | 2022 | 161 | 0.050 |
Why?
| | Personal Satisfaction | 1 | 2023 | 182 | 0.050 |
Why?
| | Malawi | 1 | 2021 | 48 | 0.050 |
Why?
| | Prostheses and Implants | 1 | 2022 | 138 | 0.050 |
Why?
| | Cluster Analysis | 1 | 2022 | 460 | 0.050 |
Why?
| | Tonometry, Ocular | 1 | 2021 | 83 | 0.050 |
Why?
| | Accidental Falls | 1 | 2023 | 150 | 0.050 |
Why?
| | Hearing Loss, Conductive | 1 | 2020 | 22 | 0.050 |
Why?
| | Risk Assessment | 2 | 2020 | 2973 | 0.050 |
Why?
| | Benchmarking | 1 | 2022 | 161 | 0.050 |
Why?
| | Biomarkers | 2 | 2021 | 3416 | 0.050 |
Why?
| | Gastrointestinal Agents | 1 | 2021 | 60 | 0.040 |
Why?
| | Cough | 1 | 2021 | 107 | 0.040 |
Why?
| | Iron | 1 | 2022 | 234 | 0.040 |
Why?
| | Fitness Trackers | 1 | 2020 | 8 | 0.040 |
Why?
| | Developmental Disabilities | 1 | 2023 | 239 | 0.040 |
Why?
| | Noise | 1 | 2021 | 68 | 0.040 |
Why?
| | ROC Curve | 1 | 2021 | 445 | 0.040 |
Why?
| | United Arab Emirates | 1 | 2020 | 5 | 0.040 |
Why?
| | Reoperation | 1 | 2022 | 514 | 0.040 |
Why?
| | Iduronidase | 1 | 2019 | 2 | 0.040 |
Why?
| | Los Angeles | 1 | 2020 | 56 | 0.040 |
Why?
| | Ultrasonography, Doppler, Pulsed | 1 | 2019 | 6 | 0.040 |
Why?
| | Competency-Based Education | 1 | 2020 | 66 | 0.040 |
Why?
| | Waist Circumference | 1 | 2020 | 122 | 0.040 |
Why?
| | Colorado | 2 | 2019 | 4086 | 0.040 |
Why?
| | Abdominoplasty | 1 | 2019 | 6 | 0.040 |
Why?
| | Piperidines | 1 | 2021 | 161 | 0.040 |
Why?
| | Fundoplication | 1 | 2020 | 51 | 0.040 |
Why?
| | Trauma Centers | 1 | 2022 | 325 | 0.040 |
Why?
| | Dermatologic Surgical Procedures | 1 | 2019 | 19 | 0.040 |
Why?
| | Collagen | 1 | 2022 | 415 | 0.040 |
Why?
| | Blood Transfusion | 1 | 2022 | 276 | 0.040 |
Why?
| | Fathers | 1 | 2019 | 45 | 0.040 |
Why?
| | Biomarkers, Pharmacological | 1 | 2019 | 26 | 0.040 |
Why?
| | Glucocorticoids | 1 | 2023 | 532 | 0.040 |
Why?
| | Intraocular Pressure | 1 | 2021 | 276 | 0.040 |
Why?
| | Hemodynamics | 1 | 2023 | 1013 | 0.040 |
Why?
| | Analgesics | 1 | 2020 | 158 | 0.040 |
Why?
| | Glycosaminoglycans | 1 | 2019 | 79 | 0.040 |
Why?
| | Heterozygote | 1 | 2019 | 251 | 0.040 |
Why?
| | Mupirocin | 1 | 2018 | 7 | 0.040 |
Why?
| | Mouthwashes | 1 | 2018 | 12 | 0.040 |
Why?
| | Endoscopy, Digestive System | 1 | 2020 | 110 | 0.040 |
Why?
| | Young Adult | 3 | 2019 | 10463 | 0.040 |
Why?
| | Patient Care Bundles | 1 | 2018 | 17 | 0.040 |
Why?
| | Staff Development | 1 | 2018 | 39 | 0.040 |
Why?
| | Drug Administration Schedule | 1 | 2020 | 718 | 0.040 |
Why?
| | Guidelines as Topic | 1 | 2020 | 244 | 0.040 |
Why?
| | Mortality | 1 | 2020 | 288 | 0.040 |
Why?
| | Chlorhexidine | 1 | 2018 | 22 | 0.040 |
Why?
| | Administration, Intranasal | 1 | 2018 | 75 | 0.040 |
Why?
| | Precancerous Conditions | 1 | 2020 | 158 | 0.040 |
Why?
| | Superficial Back Muscles | 1 | 2018 | 13 | 0.040 |
Why?
| | Nasal Cavity | 1 | 2018 | 47 | 0.040 |
Why?
| | Catheters | 1 | 2018 | 63 | 0.040 |
Why?
| | Self Administration | 1 | 2018 | 123 | 0.040 |
Why?
| | Carrier State | 1 | 2018 | 54 | 0.040 |
Why?
| | Endoscopy, Gastrointestinal | 1 | 2020 | 204 | 0.040 |
Why?
| | Comorbidity | 1 | 2022 | 1449 | 0.040 |
Why?
| | Patient Satisfaction | 1 | 2021 | 583 | 0.040 |
Why?
| | Fellowships and Scholarships | 1 | 2020 | 227 | 0.040 |
Why?
| | Endoscopy | 1 | 2020 | 248 | 0.040 |
Why?
| | Time-to-Treatment | 1 | 2018 | 147 | 0.040 |
Why?
| | Arrhythmias, Cardiac | 1 | 2019 | 278 | 0.040 |
Why?
| | Postoperative Period | 1 | 2018 | 289 | 0.040 |
Why?
| | Hospital Mortality | 1 | 2021 | 776 | 0.040 |
Why?
| | Lipoproteins, VLDL | 1 | 2016 | 21 | 0.030 |
Why?
| | Africa | 1 | 2017 | 95 | 0.030 |
Why?
| | Cost-Benefit Analysis | 1 | 2019 | 545 | 0.030 |
Why?
| | Socioeconomic Factors | 1 | 2020 | 1078 | 0.030 |
Why?
| | Risk | 1 | 2019 | 815 | 0.030 |
Why?
| | Body Constitution | 1 | 2016 | 47 | 0.030 |
Why?
| | Birth Weight | 1 | 2019 | 440 | 0.030 |
Why?
| | Recombinant Proteins | 1 | 2019 | 1233 | 0.030 |
Why?
| | Diet, Reducing | 1 | 2016 | 76 | 0.030 |
Why?
| | Preoperative Care | 1 | 2018 | 317 | 0.030 |
Why?
| | Premature Birth | 1 | 2019 | 276 | 0.030 |
Why?
| | Delivery of Health Care | 1 | 2023 | 833 | 0.030 |
Why?
| | Databases, Factual | 1 | 2020 | 1128 | 0.030 |
Why?
| | Absorptiometry, Photon | 1 | 2016 | 224 | 0.030 |
Why?
| | Education, Medical | 1 | 2018 | 216 | 0.030 |
Why?
| | Metabolic Diseases | 1 | 2016 | 99 | 0.030 |
Why?
| | Aortic Valve | 1 | 2019 | 400 | 0.030 |
Why?
| | Military Personnel | 1 | 2022 | 523 | 0.030 |
Why?
| | Survival Rate | 1 | 2019 | 1642 | 0.030 |
Why?
| | Liver | 1 | 2023 | 1631 | 0.030 |
Why?
| | Algorithms | 1 | 2022 | 1468 | 0.030 |
Why?
| | Risk Reduction Behavior | 1 | 2016 | 201 | 0.030 |
Why?
| | Fetal Growth Retardation | 1 | 2019 | 467 | 0.030 |
Why?
| | Behavior Therapy | 1 | 2016 | 226 | 0.030 |
Why?
| | Staphylococcal Infections | 1 | 2018 | 336 | 0.030 |
Why?
| | Quality Improvement | 1 | 2021 | 951 | 0.030 |
Why?
| | Registries | 1 | 2021 | 1759 | 0.030 |
Why?
| | Health Services Accessibility | 1 | 2019 | 763 | 0.030 |
Why?
| | Logistic Models | 1 | 2018 | 1843 | 0.030 |
Why?
| | Muscle, Skeletal | 1 | 2022 | 1472 | 0.030 |
Why?
| | Primary Health Care | 1 | 2023 | 1515 | 0.030 |
Why?
| | Disease Progression | 1 | 2020 | 2387 | 0.030 |
Why?
| | Double-Blind Method | 1 | 2016 | 1662 | 0.030 |
Why?
| | Parents | 1 | 2019 | 1190 | 0.020 |
Why?
| | Insulin | 1 | 2020 | 2079 | 0.020 |
Why?
| | Diet | 1 | 2017 | 1080 | 0.020 |
Why?
|
|
Kaizer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|